Daniel Faga - Mar 21, 2022 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Role
Interim CEO, Director
Signature
/s/ Eric Loumeau, Attorney-in-Fact
Stock symbol
ANAB
Transactions as of
Mar 21, 2022
Transactions value $
$0
Form type
4
Date filed
3/23/2022, 04:48 PM
Previous filing
Feb 14, 2022
Next filing
Jan 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANAB Common Stock Award $0 +887K $0.00 887K Mar 21, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Certain of the restricted stock units are subject to forfeiture to the Issuer if underlying vesting conditions are not met.